In the latest trading session, 0.4 million Traws Pharma Inc (NASDAQ:TRAW) shares changed hands as the company’s beta touched 0.91. With the company’s most recent per share price at $10.90 changed hands at -$1.67 or -13.29% at last look, the market valuation stands at $32.98M. TRAW’s current price is a discount, trading about -82.94% off its 52-week high of $19.94. The share price had its 52-week low at $4.06, which suggests the last value was 62.75% up since then. When we look at Traws Pharma Inc’s average trading volume, we note the 10-day average is 2.84 million shares, with the 3-month average coming to 454.06K.
Traws Pharma Inc (NASDAQ:TRAW) trade information
Instantly TRAW was in red as seen in intraday trades today. With action 114.94%, the performance over the past five days has been green. The company’s shares are showing year-to-date upside of 16.95%, with the 5-day performance at 114.94% in the green. However, in the 30-day time frame, Traws Pharma Inc (NASDAQ:TRAW) is 144.14% up. Looking at the short shares, we see there were 7389.0 shares sold at short interest cover period of 0.62 days.
Traws Pharma Inc (TRAW) estimates and forecasts
Year-over-year growth is forecast to reach 1.77% up from the last financial year.
Consensus estimates given by 1 financial analysts project the company’s revenue in the current quarter to hit an average of 60k. 1 analysts are of the opinion that Traws Pharma Inc’s revenue for the current quarter will be 60k. The company’s revenue for the corresponding quarters a year ago was 56k and 56k respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at 7.14%. The estimates for the next quarter sales put growth at 7.14%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 58.67%. The 2024 estimates are for Traws Pharma Inc earnings to decrease by -586.00%.
Traws Pharma Inc (NASDAQ:TRAW)’s Major holders
Among Mutual Funds, the top two as of Sep 30, 2024 were Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund. With 13.75 shares estimated at $0.16 million under it, the former controlled 0.45% of total outstanding shares. On the other hand, Vanguard Extended Market Index Fund held about 0.43% of the shares, roughly 12.88 shares worth around $0.15 million.
